Yijiada Medical Technology (Shanghai)
A high-tech company focusing on specialist medical devices and specialist management
About Yijiada Medical Technology (Shanghai)
Yijiada Medical Technology (Shanghai) Co., Ltd., operating as Better MedTech, is a high-tech enterprise established in 2021. The company focuses on the development, manufacturing, sales, and service of specialized medical devices. Its primary market is within the diagnostic equipment industry, with a particular emphasis on urology and pelvic health. Yijiada aims to provide precise treatment solutions to improve the quality of life for patients in this sector.
The firm's product lines target conditions such as benign prostatic hyperplasia and urinary system stones, and also include endoscopic equipment. The business operates out of its headquarters in Shanghai, China, which includes a significant research and development center and a production base in the Jiading District. This facility houses a 500-square-meter Class 10,000 clean workshop and a 1,000-square-meter R&D center, providing substantial infrastructure for its research team.
Since its inception, Yijiada has successfully raised $14.1 million in funding, with its initial seed round occurring in November 2021. The company has attracted investments from several venture capital firms, including Lotus Lake Ventures, Sunland Fund, Vision Plus Capital, CDBI Partners, and Everest VC. This financial backing supports the company's efforts in research and development, as well as the expansion of its service capabilities. Yijiada provides comprehensive technical support and on-site training for its products, underscored by a professional service team dedicated to ensuring a positive customer experience throughout the entire process, from pre-sales to after-sales support.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 12.0/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2024 | $14M | $55M | Hetang Venture Capital Management (Beijing) · Sunland fund · Vision Plus Capital | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Yijiada Medical Technology (Shanghai) in its local ecosystem
The Yijiada Medical Technology (Shanghai) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- H(Hetang Venture Capital Management (Beijing)
Sunland fund
Vision Plus Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Yijiada Medical Technology (Shanghai) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yijiada Medical Technology (Shanghai)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.